Ausgabe 3-4/2002
Inhalt (17 Artikel)
Review
Problems of case and disease management in outpatient treatment of influenza
Klaus-Dieter Kossow
Original Investigation
Antigenic drift and variability of influenza viruses
B. Schweiger, I. Zadow, R. Heckler
Original Investigation
Real-time influenza surveillance in Germany – Results of a pilot project
W. Lange, M. Schöttler
Original Investigation
Some aspects regarding the interpretation of influenza surveillance data
H. Uphoff, J. Cohen
Original Investigation
Acute respiratory diseases/influenza sentinel 2000/2001
S. Bigl, I. Briem, R. Drechsler, D. Kluge, L. Müller, G. Nowotnik
Review
Laboratory diagnosis of influenza – virology or serology?
R. Allwinn, W. Preiser, H. Rabenau, S. Buxbaum, M. Stürmer, H. Doerr
Review
Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment
Adrian Gillissen, Gert Höffken
Clinical Practice
Neuraminidase inhibitors in the management of influenza – experience of an outpatient practice
Georg E. Vogel
Review
Efficacy and safety of zanamivir in patients with influenza – impact of age, severity of infections and specific risk factors
Gert Höffken, Adrian Gillissen
Original Investigation
Cyanobacteria a potential source of antiviral substances against influenza virus
E. Zainuddin, S. Mundt, U. Wegner, R. Mentel
Viewpoint
Conceptional considerations for a German influenza pandemic preparedness plan
R. Fock, H. Bergmann, H. Bussmann, G. Fell, E.-J. Finke, U. Koch, M. Niedrig, M. Peters, D. Scholz, A. Wirtz
Original Investigation
Experience with the clinical development of influenza vaccines for potential pandemics
J. Wood, K. Nicholson, I. Stephenson, M. Zambon, R. Newman, D. Major, A. Podda
Original Investigation
Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines
N. Hehme, H. Engelmann, W. Künzel, E. Neumeier, R. Sänger